
Draft document on the evaluation criteria for the attribution of therapeutic innovativeness
On March 12, 2025, AIFA published the draft document on the “Evaluation Criteria for the Attribution of Therapeutic Innovation and the Management of Antiinfective Agents for Multidrug-Resistant